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Abstract
Patients palliated with Fontan circulation who require mechanical circulatory
support pose anatomic and physiologic challenges. We treated an acutely failed
Fontan patient with sequential temporary and durable support devices. Aspects
of treatment with each device required modification based on the patient’s
anatomy and physiology.
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Patient Profile
A 32-year-old man with Damus-Kaye-Stansel reconstruction and Fontan
palliation for double inlet left ventricle and L-transposition suffered cardiac arrest
and gross aspiration. Bystander CPR was initiated with return of spontaneous
circulation after 30 minutes. On arrival to the hospital he was intubated and
found to be neurologically intact, in cardiogenic shock, anuric, and requiring
multiple vasoactive infusions. Creatinine was 3.7 mg/dL, international
normalized ratio was 1.6, and total bilirubin level was 3.2 mg/dL.
Echocardiogram showed moderate ventricular dysfunction and mild-moderate
neo-aortic insufficiency (neo-AI). Catheterization revealed unobstructed Fontan
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circuit with pressures = 23mmHg (catheterization 6 months earlier = 16mmHg).
INTERMACS classification was one.
An Impella 5.0 (Abiomed, Danvers, MA) ventricular assist device (VAD) was
placed via right axillary cutdown. Impella passage into the left ventricle, through
the native pulmonary valve resulted in severe neo-AI. Repositioning through the
native aortic valve, into the rudimentary right ventricular outflow chamber,
allowed full flow and stabilization. Persistent hemolysis and mucosal bleeding
prompted Impella removal and HeartWare HVAD® (HeartWare, Framingham,
MA) placement 10 days later as attempts at Impella weaning caused
hemodynamic embarrassment. The long-term goal for the patient was HVAD as
bridge to transplant.
The HVAD was placed in a hybrid OR via left anterior thoracotomy and left
axillary cutdown without bypass. Epicardial ultrasound guided cannula position.
Left pleural adhesions and chest-wall to pulmonary collaterals mandated
subcutaneous outflow graft placement. The distal axillary artery was banded to
prevent unilateral hyperemia. Endovascular semilunar valve closure was
attempted with a 30mm Amplatzer ventricular septal defect occluder in an
attempt to minimize neo-AI. It was thought this device would sit nicely within the
sinus segment of the neo-aortic valve. Deployment of the device caused
hemodynamic collapse due to coronary compression, which was relieved with resheathing and removal of the device.
We think the coronary compression was related to over-sizing, but a size 28mm
device did not have adequate leaflet capture to ensure positional stability. Due to
hemodynamic instability, it was not possible to ascertain whether the device
occluded a coronary os directly or by means of distortion/torsion.
The patient made a slow recovery marked by dialysis dependence, extreme
deconditioning, and nosocomial pneumonias before dying on POD 273. There
were some bright spots during his prolonged hospitalization, as he remained
neurologically intact and enjoyed some quality of life given his ability to eat and
mobilize via a wheelchair. He was also able to take a day trip to a major league
baseball game.

Comment
Since the Fontan circulation is susceptible to failure at multiple levels, a single
approach to Fontan failure patients is unrealistic and mechanical therapies must
be individualized. Impella for single ventricle support as a bridge to Berlin Heart
(Berlin Heart Inc., The Woodlands, TX)1 in a pediatric patient has been reported,
but use in adult Fontan circulation has not.
Determining the physiologic cause of Fontan failure is imperative. Fontan
obstruction or elevated pulmonary vascular resistance (PVR) are not remedied
with ventricular assist therapies.2 In this case, failure was caused by combined
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acute decline in ventricular function and aspiration causing elevated PVR. Such
patients are typically supported with veno-arterial extracorporeal membrane
oxygenation (VA-ECMO). This patient was not a good VA-ECMO candidate
given the degree of neo-AI.
This patient presented anatomic challenges. Impella placement into the left
ventricle, across the patient’s neo-aortic valve resulted in unacceptable neo-AI,
whereas placement into the rudimentary right ventricle (across the native aortic
valve) allowed full flow and adequate support (Figure 1). We elected to place the
HVAD via a non-sternotomy approach given the overall clinical situation and
ongoing failure of multiple organ systems. The LV apex was accessible by left
anterior thoracotomy. Epicardial and transesophageal echocardiography guided
precise cannula placement.3 Left pleural symphysis and chest wall to pulmonary
collaterals mandated extra-thoracic outflow graft placement. Outflow graft
placement inside ring reinforced polytetrafluoroethylene prevented kinking or
stenosis (Figure 2). Coronary anatomy prevented minimization of neo-AI by
endovascular closure device.

Figure 1. Echocardiogram image shows Impella device in rudimentary right
ventricular outflow chamber with tip of device near the bulboventricular foramen
(BVF).
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Figure 2. Post-operative CT scan of the chest showing VAD in cardiac apex and
extra-thoracic course of outflow graft.
The optimal management of acute Fontan circulation failure is unknown. We had
technical success employing a temporary, intravascular axial flow ventricular
assist device as a bridge to durable VAD. Congenital anatomy presents unique
challenges in caring for these patients and requires flexibility and adaptability
when using devices designed for normal anatomy.
Ultimate success was not achieved in this case. However, the experience with
this patient remains valuable to the still nascent literature regarding mechanical
support of this disease state. Fontan circulation patients represent the fastest
growing population of adults with congenital heart disease and this scenario will
be confronted with increased frequency in the foreseeable future.4 Some of the
technical challenges related to this patient’s anatomy are unique to patients with
congenital disease and worth noting for treating future patients. The value of a
multi-disciplinary team of surgeons, interventionalists, and cardiologists with
expertise in adult congenital heart disease as well as a dedicated cardiothoracic
ICU cannot be overemphasized in the care of these patients.
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